|
|
|
Insider
Information: |
Guerin Mark Patrick |
Relationship: |
|
City: |
Newtown |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
35,976 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$26,262 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
35,976 |
|
|
Total
Value |
$26,262 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
4
|
0
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
Percentage
Gain/Loss : |
134.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onconova Therapeutics, Inc. |
ONTX |
|
2024-03-14 |
35,976 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2024-03-14 |
4 |
D |
$0.90 |
$2,332 |
D/D |
(2,591) |
35,976 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2024-03-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,666 |
38,567 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2024-02-07 |
4 |
D |
$0.67 |
$1,637 |
D/D |
(2,443) |
29,901 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2024-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,900 |
32,344 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2023-08-03 |
4 |
D |
$1.02 |
$1,450 |
D/D |
(1,422) |
25,444 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2023-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
26,866 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2023-06-12 |
4 |
D |
$1.14 |
$1,791 |
D/D |
(1,575) |
22,116 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2023-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,500 |
23,691 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2023-02-07 |
4 |
D |
$1.36 |
$2,428 |
D/D |
(1,785) |
18,191 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2023-02-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,900 |
19,976 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2022-08-03 |
4 |
D |
$1.32 |
$1,789 |
D/D |
(1,355) |
13,076 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
CFO AND COO |
|
2022-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
14,431 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
Chief Financial Officer |
|
2021-02-16 |
4 |
B |
$1.00 |
$15,000 |
D/D |
15,000 |
145,213 |
2.74 |
% |
|
ONTX |
Onconova Therapeutics, In... |
Chief Financial Officer |
|
2020-11-27 |
4 |
B |
$0.26 |
$1,200 |
D/D |
4,614 |
130,213 |
2.66 |
% |
|
ONTX |
Onconova Therapeutics, In... |
Chief Financial Officer |
|
2020-11-25 |
4 |
B |
$0.26 |
$4,356 |
D/D |
16,755 |
125,599 |
2.66 |
% |
|
ONTX |
Onconova Therapeutics, In... |
Chief Financial Officer |
|
2020-05-19 |
4 |
B |
$0.36 |
$7,560 |
D/D |
21,000 |
108,844 |
2.74 |
% |
|
ONTX |
Onconova Therapeutics, In... |
Chief Financial Officer |
|
2019-11-25 |
4 |
B |
$0.20 |
$17,500 |
D/D |
87,500 |
87,844 |
2.74 |
- |
|
ONTX |
Onconova Therapeutics, In... |
Chief Financial Officer |
|
2017-04-26 |
4 |
B |
$2.10 |
$3,001 |
D/D |
1,429 |
5,155 |
2.66 |
- |
|
ONTX |
Onconova Therapeutics, In... |
Chief Accounting Officer |
|
2016-07-29 |
4 |
OE |
$4.10 |
$15,031 |
D/D |
3,666 |
3,726 |
0 |
- |
|
ONTX |
Onconova Therapeutics, In... |
Chief Accounting OfficerOffice |
|
2014-05-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
600 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|